简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-06-23 19:06 Pacific Prime Opens Its ‘Scholarship Program 2022’ for Students in Asia Pacific
2022-06-22 14:28 Galderma Announces Positive Data From Phase III Trial, Demonstrating Efficacy and Safety of nemolizumab in Patients with Prurigo Nodularis
2022-06-21 14:36 AOP Health Presents Final Results From Its CONTINUATION-PV Study - up to 7.5 Years Treatment With BESREMi® (Ropeginterferon alfa-2b) of Polycythaemia Vera Patients - at EHA 2022 Annual Meeting
2022-06-21 14:33 Solasia Pharma: DARVIAS® Injection 135mg (Generic Name: DARINAPARSIN /Development Code: SP-02) Approved in Japan
2022-06-17 17:13 IFPMA: Pharmaceutical Industry Expresses Deep Disappointment With Decision on Waiving Intellectual Property Rights Adopted at the World Trade Organization Ministerial Conference
2022-06-17 10:43 GC Aesthetics® Announces Growth and Expansion in Brazil
2022-06-16 18:59 F45 Training Opens a New Chapter of Work-Life Balance for the Kwun Tong Workers
2022-06-16 16:51 Saint-Gobain Bioprocess Solutions Business Announces C-Flex® Production Capability in Suwa, Japan
2022-06-16 14:24 Neuron Physiology & Sports Injury Centre - Why choose a physical therapist with expertise or experience in pediatrics?
2022-06-16 14:20 ValGenesis Acquires 4Tune Engineering, Extends Product Portfolio with Best-in-Class Risk Management and Continuous Process Verification Software Platforms
2022-06-16 10:27 KBI Biopharma SA and Selexis SA Expand in Europe by Opening an Integrated Biologics Manufacturing Facility in Geneva, Switzerland
2022-06-16 10:18 Waters Introduces High Resolution Mass Spectrometry Products and Software to Accelerate Drug Development
2022-06-15 16:46 Guardant Health Completes Purchase of Guardant Health AMEA Joint Venture
2022-06-15 09:52 Boehringer Ingelheim signs Option to Acquire Trutino Biosciences
2022-06-14 13:12 Children's Hospital Los Angeles: The Best Care for Kids in California and the West Coast
2022-06-13 09:22 Galderma Announces Positive Results in Two Phase III Studies for a Novel Liquid Formulation botulinumtoxinA (RelabotulinumtoxinA) for the Treatment of Glabellar Lines (frown) and Lateral Canthal Lines (crow’s Feet)
2022-06-10 16:20 Ferring Announces New Collaboration for Development of Olamkicept
2022-06-10 15:58 Takeda’s Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Through 4.5 Years in Pivotal Clinical Trial
2022-06-09 10:40 Exscientia to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
2022-06-08 15:18 Galderma to Present New Findings From Innovative Product Portfolio at the 2022 VCS Annual Symposium

Business Wire Weibo

Press Releases

Latest Releases